Brandywine Global Investment Management LLC Acquires 21,435 Shares of Tenet Healthcare Corporation $THC

Brandywine Global Investment Management LLC increased its holdings in Tenet Healthcare Corporation (NYSE:THC) by 20.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 126,248 shares of the company’s stock after purchasing an additional 21,435 shares during the period. Brandywine Global Investment Management LLC’s holdings in Tenet Healthcare were worth $25,088,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Boston Partners boosted its stake in Tenet Healthcare by 38.8% during the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares during the period. Ameriprise Financial Inc. boosted its stake in Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after buying an additional 157,109 shares during the period. AQR Capital Management LLC boosted its position in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after buying an additional 720,160 shares during the period. Norges Bank purchased a new position in shares of Tenet Healthcare during the fourth quarter valued at approximately $248,494,000. Finally, Eminence Capital LP purchased a new position in shares of Tenet Healthcare during the third quarter valued at approximately $225,263,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on THC shares. Jefferies Financial Group boosted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Weiss Ratings lowered shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. Morgan Stanley set a $254.00 target price on shares of Tenet Healthcare in a research note on Friday, May 1st. Royal Bank Of Canada lowered their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Finally, Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Eighteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Insider Buying and Selling

In related news, EVP Paola M. Arbour sold 6,500 shares of the company’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 15,138 shares of company stock valued at $3,065,789 over the last three months. 0.97% of the stock is owned by company insiders.

Tenet Healthcare Stock Up 0.6%

NYSE:THC opened at $163.02 on Tuesday. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21. The company has a 50-day moving average of $185.53 and a 200 day moving average of $200.59. The firm has a market cap of $14.04 billion, a PE ratio of 8.48, a price-to-earnings-growth ratio of 1.33 and a beta of 1.28. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same period in the prior year, the firm earned $4.36 earnings per share. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts anticipate that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.